VJHemOnc is committed to improving our service to you

ICML 2019 | Updates in the management of CAR-T toxicities

VJHemOnc is committed to improving our service to you

Sattva Neelapu

A new consensus grading system for cytokine release syndrome, immune effector cell-associated neurotoxicity syndrome and cytopenias, potential side effects of CAR T-cell therapy, has been proposed. This is discussed here by Sattva Neelapu, MD, University of Texas MD Anderson Cancer Center, Houston, TX, at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter